Used in biomedical research to quantify levels of Prolyl Hydroxylase Domain-containing protein 3 (PHD3) in cell lysates, tissue extracts, and biological fluids. This ELISA kit enables researchers to study the role of PHD3 in hypoxia signaling pathways, particularly its involvement in regulating HIF-1α (hypoxia-inducible factor 1-alpha) stability. It is widely applied in cancer research, cardiovascular diseases, and metabolic disorder studies where oxygen sensing and cellular adaptation to low oxygen are critical. The kit supports high-throughput screening and validation of therapeutic targets related to ischemia, inflammation, and tumor progression. Suitable for both qualitative and quantitative analysis with high sensitivity and specificity.